Literature DB >> 10074486

Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha.

A Y Yu1, L A Shimoda, N V Iyer, D L Huso, X Sun, R McWilliams, T Beaty, J S Sham, C M Wiener, J T Sylvester, G L Semenza.   

Abstract

Chronic hypoxia induces polycythemia, pulmonary hypertension, right ventricular hypertrophy, and weight loss. Hypoxia-inducible factor 1 (HIF-1) activates transcription of genes encoding proteins that mediate adaptive responses to hypoxia, including erythropoietin, vascular endothelial growth factor, and glycolytic enzymes. Expression of the HIF-1alpha subunit increases exponentially as O2 concentration is decreased. Hif1a-/- mouse embryos with complete deficiency of HIF-1alpha due to homozygosity for a null allele at the Hif1a locus die at midgestation, with multiple cardiovascular malformations and mesenchymal cell death. Hif1a+/- heterozygotes develop normally and are indistinguishable from Hif1a+/+ wild-type littermates when maintained under normoxic conditions. In this study, the physiological responses of Hif1a+/- and Hif1a+/+ mice exposed to 10% O2 for one to six weeks were analyzed. Hif1a+/- mice demonstrated significantly delayed development of polycythemia, right ventricular hypertrophy, pulmonary hypertension, and pulmonary vascular remodeling and significantly greater weight loss compared with wild-type littermates. These results indicate that partial HIF-1alpha deficiency has significant effects on multiple systemic responses to chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074486      PMCID: PMC408131          DOI: 10.1172/JCI5912

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand.

Authors:  J Hu; D J Discher; N H Bishopric; K A Webster
Journal:  Biochem Biophys Res Commun       Date:  1998-04-28       Impact factor: 3.575

2.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

Authors:  H E Ryan; J Lo; R S Johnson
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1.

Authors:  L A Palmer; G L Semenza; M H Stoler; R A Johns
Journal:  Am J Physiol       Date:  1998-02

Review 4.  Pulmonary circulation at high altitude.

Authors:  R Naeije
Journal:  Respiration       Date:  1997       Impact factor: 3.580

5.  Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness.

Authors:  L C Ou; S Salceda; S J Schuster; L M Dunnack; T Brink-Johnsen; J Chen; J C Leiter
Journal:  J Appl Physiol (1985)       Date:  1998-04

6.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.

Authors:  N V Iyer; L E Kotch; F Agani; S W Leung; E Laughner; R H Wenger; M Gassmann; J D Gearhart; A M Lawler; A Y Yu; G L Semenza
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

7.  Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1.

Authors:  C Martin; A Y Yu; B H Jiang; L Davis; D Kimberly; A R Hohimer; G L Semenza
Journal:  Am J Obstet Gynecol       Date:  1998-03       Impact factor: 8.661

8.  Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia.

Authors:  S I Tazuke; N M Mazure; J Sugawara; G Carland; G H Faessen; L F Suen; J C Irwin; D R Powell; A J Giaccia; L C Giudice
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.

Authors:  W Steudel; M Scherrer-Crosbie; K D Bloch; J Weimann; P L Huang; R C Jones; M H Picard; W M Zapol
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

10.  Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells.

Authors:  M Tucci; K Nygard; B V Tanswell; H W Farber; D J Hill; V K Han
Journal:  J Endocrinol       Date:  1998-04       Impact factor: 4.286

View more
  242 in total

1.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Authors:  N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1.

Authors:  G L Semenza
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry.

Authors:  Yingfeng Wang; Wenju Lu; Kai Yang; Yan Wang; Jie Zhang; Jing Jia; Xin Yun; Lichun Tian; Yuqin Chen; Qian Jiang; Bo Zhang; Xiuqing Chen; Jian Wang
Journal:  J Mol Med (Berl)       Date:  2014-11-14       Impact factor: 4.599

4.  Physiology meets biophysics: visualizing the interaction of hypoxia-inducible factor 1 alpha with p300 and CBP.

Authors:  Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-19       Impact factor: 11.205

5.  Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.

Authors:  Rubin M Tuder; Laura A Davis; Brian B Graham
Journal:  Am J Respir Crit Care Med       Date:  2011-11-10       Impact factor: 21.405

Review 6.  Complex role of the HIF system in cardiovascular biology.

Authors:  Gabor Czibik
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

Review 7.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

8.  The aquaporin 1 C-terminal tail is required for migration and growth of pulmonary arterial myocytes.

Authors:  Ning Lai; Julie Lade; Kyle Leggett; Xin Yun; Syeda Baksh; Eric Chau; Michael T Crow; Venkataramana Sidhaye; Jian Wang; Larissa A Shimoda
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

Review 9.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

10.  Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.

Authors:  Gregory B Waypa; Scott W Osborne; Jeremy D Marks; Sara K Berkelhamer; Jyothisri Kondapalli; Paul T Schumacker
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.